放射科医师实施的透视引导下颈段椎板间硬膜外类固醇注射的安全性结局与疼痛评分改善
本研究回顾性纳入2016年10月至2022年10月间放射科医师在门诊实施的251次C7-T1水平透视引导下颈段椎板间硬膜外类固醇注射(每次1.0 mL 10 mg/mL地塞米松,不加硬膜外麻醉药),186例患者平均临床随访28.5个月。无患者出现重大并发症;218次注射有注射后疼痛评分,平均随访11.8天,NRS评分从注射前平均5.2/10降至3.0/10(p < .0001),117例患者(53.7%)报告疼痛改善≥50%。作者结论认为该技术安全有效。
要点
- 注射前平均NRS 5.2/10,注射后平均3.0/10(p < .0001),218次注射有注射后评分。
- 251次注射中无患者发生重大并发症。
- 117例患者(53.7%)报告疼痛改善≥50%,既往有注射史者更可能报告≥50%改善(p = .012)。
核心结论
- 放射科医师实施的C7-T1水平透视引导下颈段椎板间硬膜外类固醇注射在颈段病变患者管理中安全有效。
研究设计与样本
- 回顾性研究,利用机构数据库识别2016年10月至2022年10月间的颈段注射,共251次注射(186例患者)符合纳入标准,所有注射均在C7-T1水平使用1.0 mL 10 mg/mL地塞米松且不加硬膜外麻醉药,采用NRS评估疼痛改善,复习颈椎MRI评估注射前病变严重程度,查阅病历记录注射后并发症。
诊断标准与关键数值
- 疼痛评估采用数值评定量表(NRS),注射前平均5.2/10,注射后平均3.0/10,p < .0001。
- 218/251次注射(86.9%)有注射后疼痛评分,平均随访11.8天(范围6 - 57天)。
- 117例患者(53.7%)报告疼痛改善≥50%。
- 既往有注射史的患者在后续注射后更可能报告≥50%疼痛改善(p = .012)。
临床应用与阅片要点
- 本研究中心的做法是常规在门诊由放射科医师实施透视引导下颈段椎板间硬膜外类固醇注射。
- 注射前可复习颈椎MRI评估颈段病变严重程度。
- 注射后随访记录NRS评分及有无并发症。
局限性
- 本研究为回顾性研究。
- 251次注射中仅218次(86.9%)有注射后疼痛评分,平均随访11.8天(范围6 - 57天)。
- 平均临床随访28.5个月(范围0.2 - 73.0个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: Image-guided spine injections are an important tool in the management of patients with a variety of spinal pathologies. Our practice offers radiologist-performed fluoroscopy-guided interlaminar cervical epidural steroid injection (ESI) routinely performed in the outpatient setting. The purpose of this study was to evaluate clinical outcomes and improvement in pain scores after radiologist-performed cervical ESI.
METHODS: An institutional database was used to retrospectively identify cervical injections performed between October 2016 and October 2022. All injections were performed at the C7-T1 level utilizing 1.0 mL of 10 mg/mL dexamethasone without epidural anesthetic. The Numerical Rating Scale (NRS) was used to assess pain improvement. Cervical MRI was reviewed to assess pre-injection cervical disease severity. Patient charts were reviewed for any post-injection complications.
RESULTS: A total of 251 cervical injections in 186 patients met our inclusion criteria with mean clinical follow up of 28.5 months (range 0.2 - 73.0 months). No patients experienced any major complications after injection. Post-injection pain scores were available for 218 of 251 injections (86.9%) with mean follow-up of 11.8 days (range 6 - 57 days). There was a significant improvement in pain scores from a mean pre-injection NRS score of 5.2/10 to 3.0/10 (p < .0001). 117 patients (53.7%) reported ≥ 50% improvement after injection. Patients who had prior injection were more likely to report ≥ 50% pain improvement after subsequent injection (p = .012).
CONCLUSION: Radiologist-performed fluoroscopy-guided interlaminar cervical ESI at the C7-T1 level is a safe and effective tool in the management of patients with cervical pathology.
引用
- Guntin J, Regalado L, Serhal A, et al. Safety outcomes and improvement in pain scores after radiologist-performed fluoroscopy-guided interlaminar cervical epidural steroid injection. Skeletal Radiol. 2023. PMID: 38110779. doi:10.1007/s00256-023-04548-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。